Anemia Treatment Drugs Industry
Anemia treatment drugs Industry accounted for a market value of US$ 23,155.8 Mn in 2017 and projected to grow at a CAGR of 16.4% during the forecast period from 2018 to 2026.
An abnormal decrease in the level of red blood cells, irregular red blood cell morphology, or inadequate concentration of haemoglobin in the blood results in anemia. Anemia is caused also due to numerous nutritional and non-nutritional factors such as infectious disease including malaria, soil-transmitted- helminthiasis, hookworm, and tuberculosis). The World Health Organization (WHO) estimated that globally anemia prevalence averaged 56%, with geographical variations in Europe & Asia the prevalence is in a range from 35% to 75%.
Browse the full report Anemia Treatment Drugs Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/anemia-treatment-drugs-market
According to the American Society of Hematology, anemia is the most common hematological disorder and affects more than 3 million Americans every year. The global scenario is more concerning because the World Health organization states that globally around 1.62 billion people gets affected by anemia, which is equal to 22.5% of the global population. In addition to that highest prevalence of anemia was found in the preschool-age children, and the lowest prevalence is in men. Furthermore, the highest number of individuals affected with anemia after pre-school-age children are non-pregnant women which is around 31.2% of the total anemic population. The treatment specifically depends on the type of anemia and other complications associated with it. Currently, the treatment for anemia specifically focuses on supplements and chronic conditions are directly treated with blood transfusion, stem cell transplant or bone marrow transplant.
Report Scope by Segments
This report on anemia treatment drugs market provides detailed information related to market dynamics such as restraints, drivers, & opportunities along with global trends. The report provides broad summary of the global anemia treatment drugs market by segmenting the market based on anemia type, drug type, and geography. The objective of publishing this in-depth research report is to assist the industry stakeholders in carrying-out strategic decisions and implementation in the anemia treatment drugs market.
Anemia Type Segment (2016–2026; US$ Mn)
- Iron deficiency anemia
- Aplastic anemia
- Hemolytic anemia
- Sickle cell anemia
- Pernicious anemia
Drug Type Segment (2016–2026; US$ Mn)
- Bone Marrow Stimulants
- Gene Therapy
- Iron Chelating Agents
Geography Segment (2016–2026; US$ Mn)
- North America
- United States
- United Kingdom
- Rest of Europe
- Asia Pacific (APAC)
- Rest of APAC
- Latin America (LATAM)
- Rest of LATAM
- Middle East and Africa (MEA)
- Rest of MEA
This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to assist in better understanding of global anemia treatment drugs market. The major players analyzed based on their product offering, market strategies, recent developments, and business strength. The report also provides attractive investment proposition based on the exhaustive geographical research carried out based on PESTEL analysis. Major companies profiled in the report include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals, GlaxoSmithKline plc, Akebia Therapeutics, Vifor Pharma Management, Ltd., and FibroGen, Inc. among others.
Inquiry Before Buying: https://www.credenceresearch.com/inquiry-before-buying/59597
Key questions answered in this report
- What are anemia treatment drugs and their applications in different types of anemia?
- Which type of anemia is largest segment in global anemia treatment drugs market?
- What are the recent market trends and growth opportunities for the companies operating in anemia treatment industry?
- Which are the most attractive markets geographically for anemia treatment technology?
- What is pipeline analysis and overall future scenario of anemia treatment drugs market?
- What is the competitive landscape of anemia treatment drugs market?